摘要:
It is intended to provide a foreign protein free from any expression inducer and a process for producing the same. Namely, a process for producing a foreign protein involving the step of proliferating a recombinant Escherichia coli, which expresses the foreign protein under the control by a promoter capable of inducing the expression due to the temperature shift, by arbitrarily culturing at a low temperature and then culturing the strain at a high temperature in the absence of an expression inducer to thereby allow the expression of the foreign protein, or the step of culturing the above Escherichia coli strain at a high temperature and thus effecting the proliferation of the cells and the expression of the foreign protein at the same time; and a foreign protein free from any expression inducer which is obtained by this process. Particular examples of such foreign proteins include main tick allergens, Actinogacillus pleuropneumoniae-origin secretory macrophage toxin and a protective antigen against Erysipelothrix rhusiopathiae-infection.
摘要:
Eye drops which cause no unpleasant irritation upon dropping and have satisfactory long-term storage stability of CPB-I. The eye drops comprise CPB-I and a polyhydric alcohol, preferably one having a carbonyl value of 5 mu mol/g or lower.
摘要:
A human antihuman IL-18 antibody originating in humans, which is an antibody against human IL-18, containing an H chain complementarity determining region comprising the following polypeptide (a) or (b) and an L chain complementarity determining region to human interleukin-18 comprising the following polypeptide (c) or (d). (a) A polypeptide consisting of an amino acid sequence represented by any of SEQ ID NOS:4 to 6. (b) A polypeptide which is a modification of the polypeptide (a) and serves as an H chain complementarity determining region. (c) A polypeptide consisting of an amino acid sequence represented by any of SEQ ID NOS:10 to 12. (d) A polypeptide which is a modification of the polypeptide (c) and serves as an L chain complementarity determining region. Thus, it becomes possible to provide a human antihuman IL-18 antibody and a method of using the same.
摘要:
It is intended to provide a novel preventive/remedy for diseases with immune abnormality which can effectively act as a super-antigen without being neutralized by a neutralizing antibody to Staphylococcus enterotoxin B (SEB) known as a super-antigen. Namely, an SEB modification having a lowered reactivity with a neutralizing antibody to SEB (anti-SEB antibody) and a preventive/remedy for diseases with immune abnormality which contains this modification as the active ingredient. This SEB modification can be obtained via amino acid substitution in the amino acid sequence of SEB, in particular the amino acid sequence at the epitope part recognized by the anti-SEB antibody by using evolutionary molecular engineering techniques.
摘要:
The invention relates to a gene fragment which codes for the variable regions of an antibody having an activity of neutralizing human immunodeficiency virus (HIV), a novel recombinant anti-HIV antibody expressed by using the above gene, and a process for preparing the same. A mouse-human chimeric antibody and a modified mouse-human antibody, having an activity of neutralizing HIV, are obtained by determining a specific nucleic acid sequence of a gene fragment which codes for the variable regions of the H and L chains of an antibody having an activity of neutralizing HIV and artificially fusing a DNA synthesized on the basis of the determined sequence with a gene which codes for human immunoglobulin. The novel anti-HIV antibody is useful for treating and preventing AIDS.
摘要:
The invention provides a clinically useful monoclonal antibody which can recognize the conserved region of the V3-PND region of a glycoprotein antigen (gp120) having a molecular weight of about 120,000 Da and contained in the coat of a human immunodefiency virus (HIV) and which can neutralize a wide variety of HIV variants, or a fragment of the above antibody, and chimera and humanized antibodies derived from the above antibody. It is possible to prepare a monoclonal antibody having the activity of neutralizing various HIV variants by using as the immunogen several types of peptides having a PND tip region containing a GPGR sequence having a high conservability in the PND region of the gp120 of an HIV. It is possible to obtain a chimera antibody or an altered antibody having an anti-HIV neutralization activity effective for clinical application by transplanting a fragment of a gene coding for the variable region of the above monoclonal antibody or the complementarity-determining region of that region to a human antibody gene.
摘要:
A purpose is to provide a vaccine which can prevent porcine edema disease in farms where porcine edema disease is anticipated. Meeting this purpose is a vaccine that is a fusion protein in which Stx2eB and a polypeptide having a coiled-coil forming unit are joined or a multimer of the fusion protein, and by immunizing pigs with this vaccine, it is possible to induce potent neutralizing antibodies and to defend against the onset of porcine edema disease.
摘要:
The present invention relates to a human anti-human IL-18 antibody which reacts with human interleukin-18 (human IL-18) and does not react with a K53A variant of human IL-18.